- Report
- May 2025
- 192 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 83 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 89 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 162 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 179 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 193 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 402 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 187 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 193 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- January 2025
- 124 Pages
Global
From €2745EUR$2,999USD£2,333GBP
- Report
- October 2024
- 209 Pages
Global
From €2289EUR$2,500USD£1,945GBP
- Report
- August 2024
- 166 Pages
Global
From €2289EUR$2,500USD£1,945GBP
- Report
- April 2025
- 187 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- April 2025
- 181 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- March 2025
- 185 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- February 2025
- 182 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- February 2025
- 182 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- October 2024
- 183 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- July 2024
- 190 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- July 2024
- 189 Pages
Global
From €4119EUR$4,500USD£3,501GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more